Description

Oxidative stress markers in neural tissue following dietary supplementation with MCFAs and omega-3 PUFAs, including malondialdehyde levels and antioxidant enzyme activity.

Figure 2

Chart

Source Paper

The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer's …

Antioxidants (Basel, Switzerland) (2021)

PMID: 34943094

DOI: 10.3390/antiox10121991

Cite This Figure

![Figure 2: Oxidative stress markers in neural tissue following dietary supplementation with MCFAs and omega-3 PUFAs, including malondialdehyde levels and antioxidant enzyme activity.]()

> Source: Janine Mett "The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Depo." *Antioxidants (Basel, Switzerland)*, 2021. PMID: [34943094](https://pubmed.ncbi.nlm.nih.gov/34943094/)

<figure>
  <img src="" alt="Oxidative stress markers in neural tissue following dietary supplementation with MCFAs and omega-3 PUFAs, including malondialdehyde levels and antioxidant enzyme activity." />
  <figcaption>Figure 2. Oxidative stress markers in neural tissue following dietary supplementation with MCFAs and omega-3 PUFAs, including malondialdehyde levels and antioxidant enzyme activity.<br>  Source: Janine Mett "The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Depo." <em>Antioxidants (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34943094/">34943094</a></figcaption>
</figure>

Preuves associées

Omega-3 Fatty Acids (DHA/EPA) pour Mild Cognitive Impairment (MCI)

Note B · 18 études